The AlphaLiquid® platform enables enhanced safety,
speed and efficiency in clinical trials for drug development
Key Value Proposition
- · Customized panel design services to fulfill clinical development needs
- · Extensive oncology clinical network in Korea
- · Professional support from IMBdx medical, R&D and bioinformatics teams
- · Industry-leading assay performance at competitive prices
- · Dedicated project manager for personalized real-time services with physician
- · Real-Time tumor response monitoring to ensure patient safety during the clinical trial
